510(k) K192028

Yumizen C1200 CRP by HORIBA ABX SAS — Product Code DCK

K192028 is an FDA 510(k) premarket notification submitted by HORIBA ABX SAS for the device "Yumizen C1200 CRP". The FDA issued a decision of Substantially Equivalent on June 25, 2020. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. HORIBA ABX SAS has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 25, 2020
Date Received
July 26, 2019
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
C-Reactive Protein, Antigen, Antiserum, And Control
Device Class
Class II
Regulation Number
866.5270
Review Panel
IM
Submission Type